[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

U.S. Market for Chronic Venous Insufficiency Treatment 2009

March 2009 | 53 pages | ID: U6BD71E19E1EN
iData Research Inc.

US$ 7,495.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
CVI is the underlying cause for a majority of lower leg venous ulcers. Compression treatment with Unna boots is the most widely used treatment for venous ulcers, with over 50% of patients using them. Both the number of patients with CVI and the number of patients diagnosed is expected to increase over the forecast period, due to the aging population, increasing obesity, and growing awareness of CVI among medical professionals.
LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY


1.1 PATIENT POPULATION FOR CHRONIC VENOUS INSUFFICIENCY
1.2 UNNA BOOT MARKET
1.3 UNNA BOOT COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
  2.2.1 Step 1: Project Initiation & Team Selection
  2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
  2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
  2.2.4 Step 4: Performing Primary Research
  2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
  2.2.6 Step 6: Market Forecast and Analysis
  2.2.7 Step 7: Identify Strategic Opportunities
  2.2.8 Step 8: Final Review and Market Release
  2.2.9 Step 9: Customer Feedback and Market Monitoring

CHRONIC VENOUS INSUFFICEINCY MARKET

3.1 INTRODUCTION
3.2 CHRONIC VENOUS INSUFFICIENCY OVERVIEW
  3.2.1 Potential Patient Population
3.3 CVI PATIENTS WITH CHRONIC VENOUS ULCERS.
3.4 CHRONIC VENOUS ULCER TREATMENT BREAKDOWN
3.5 COSTS OF CVI AND VENOUS ULCERS.
3.6 CHRONIC VENOUS INSUFFICIENCY POTENTIAL MARKET
3.7 MARKET DRIVERS AND LIMITERS
  3.7.1 Market Drivers
  3.7.2 Market Limiters

UNNA BOOT MARKET

4.1 INTRODUCTION
4.2 MARKET ANALYSIS AND FORECAST
  4.2.1 Unna Boot Applications.
  4.2.2 Unna Boot Market
  4.2.3 Unna Boots Segmented by Width
  4.2.4 Unna Boot Price Segmentation
4.3 MARKET DRIVERS AND LIMITERS
  4.3.1 Market Drivers
  4.3.2 Market Limiters
4.4 COMPETITIVE ANALYSIS

LIST OF FIGURES

EXECUTIVE SUMMARY
RESEARCH METHODOLOGY.
CHRONIC VENOUS INSUFFICEINCY MARKET
Figure 3-1: Chronic Venous Insufficiency Patient Population, U.S., 2005 – 2015
Figure 3-2: Chronic Ulcer Treatment Breakdown, U.S., 2005 – 2015
Figure 3-3: Surgical CVI Treatment Potential Population, U.S., 2005 - 2015
Figure 3-4: Drivers and Limiters for the CVI Treatment Market, U.S., 2008
UNNA BOOT MARKET
Figure 4-1: Unna Boot Applications, U.S, 2005 – 2015
Figure 4-2: Unna Boot Market, U.S., 2005 – 2015
Figure 4-3: Unna Boot Units Sold by Width, U.S., 2005 – 2015
Figure 4-4: Unna Boot Price Segmentation, U.S., 2008
Figure 4-5: Drivers and Limiters for the Unna Boot Market, U.S., 2008
Figure 4-6: Leading Competitors in the Compression Bandage Market, U.S., 2008

LIST OF CHARTS

EXECUTIVE SUMMARY
Chart 1-1: CVI and Venous Ulcer Patient Populations, U.S. 2005 – 2015
Chart 1-2: Unna Boot Market, U.S., 2005 – 2015
Chart 1-3: Leading Competitors in the Unna Boot Market, U.S., 2008
RESEARCH METHODOLOGY.
CHRONIC VENOUS INSUFFICEINCY MARKET
Chart 3-1: Cost Breakdown for Venous Ulcer Treatment, U.S. 2008
UNNA BOOT MARKET
Chart 4-1: Unna Boot Market, U.S., 2005 – 2015
Chart 4-2: Unna Boot Units Sold by Width, U.S., 2005 – 2015
Chart 4-3: Unna Boot Price Segmentation, U.S., 2008
Chart 4-4: Leading Competitors in the Unna Boot Market, U.S., 2008


More Publications